These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22097923)

  • 21. Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes.
    Leaños-Miranda A; Méndez-Aguilar F; Ramírez-Valenzuela KL; Serrano-Rodríguez M; Berumen-Lechuga G; Molina-Pérez CJ; Isordia-Salas I; Campos-Galicia I
    Medicine (Baltimore); 2017 Jan; 96(4):e6005. PubMed ID: 28121958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Maternal Preeclampsia with Neonatal Respiratory Distress Syndrome in Very-Low-Birth-Weight Infants.
    Wen YH; Yang HI; Chou HC; Chen CY; Hsieh WS; Tsou KI; Tsao PN;
    Sci Rep; 2019 Sep; 9(1):13212. PubMed ID: 31519996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating angiogenic factors and placental abruption.
    Signore C; Mills JL; Qian C; Yu K; Lam C; Epstein FH; Karumanchi SA; Levine RJ
    Obstet Gynecol; 2006 Aug; 108(2):338-44. PubMed ID: 16880304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of smoking on circulating angiogenic factors in high risk pregnancies.
    Jeyabalan A; Powers RW; Clifton RG; Van Dorsten P; Hauth JC; Klebanoff MA; Lindheimer MD; Sibai B; Landon M; Miodovnik M;
    PLoS One; 2010 Oct; 5(10):e13270. PubMed ID: 20967275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of newborn serum prolactin levels to the respiratory distress syndrome and maternal hypertension.
    Grosso DS; MacDonald CP; Thomasson JE; Christian CD
    Am J Obstet Gynecol; 1980 Jul; 137(5):569-74. PubMed ID: 7386551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble Endoglin and Uterine Artery Flow Doppler Ultrasonography as Markers of Progression to Preeclampsia in Women with Gestational Hypertension.
    Molina Pérez CJ; Nolasco Leaños AG; Carrillo Juárez RI; Berumen Lechuga MG; Isordia Salas I; Leaños Miranda A
    Gynecol Obstet Invest; 2021; 86(5):445-453. PubMed ID: 34662881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of obesity on neonatal outcomes in pregnancies with preterm premature rupture of membranes.
    Faucett AM; Metz TD; DeWitt PE; Gibbs RS
    Am J Obstet Gynecol; 2016 Feb; 214(2):287.e1-287.e5. PubMed ID: 26435047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary placental growth factor and risk of preeclampsia.
    Levine RJ; Thadhani R; Qian C; Lam C; Lim KH; Yu KF; Blink AL; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    JAMA; 2005 Jan; 293(1):77-85. PubMed ID: 15632339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
    Bond DM; Middleton P; Levett KM; van der Ham DP; Crowther CA; Buchanan SL; Morris J
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004735. PubMed ID: 28257562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.
    Aggarwal S; Sunderland N; Thornton C; Xu B; Hennessy A; Makris A
    Am J Obstet Gynecol; 2017 Feb; 216(2):170.e1-170.e8. PubMed ID: 27793555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37 weeks of gestation: a 7 year retrospective analysis of a national registry.
    Langenveld J; Ravelli AC; van Kaam AH; van der Ham DP; van Pampus MG; Porath M; Mol BW; Ganzevoort W
    Am J Obstet Gynecol; 2011 Dec; 205(6):540.e1-7. PubMed ID: 21907954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy.
    Perni U; Sison C; Sharma V; Helseth G; Hawfield A; Suthanthiran M; August P
    Hypertension; 2012 Mar; 59(3):740-6. PubMed ID: 22311907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Respiratory Outcomes between Preterm Small-For-Gestational-Age and Appropriate-For-Gestational-Age Infants.
    Turitz AL; Gyamfi-Bannerman C
    Am J Perinatol; 2017 Feb; 34(3):283-288. PubMed ID: 27500933
    [No Abstract]   [Full Text] [Related]  

  • 37. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
    Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
    Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
    Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
    J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
    Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
    J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.